Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer

By Aristides M.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 775-784

Adis International

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 287-296

Adis International

Access to resources Recommend Favorite

Questioning willingness to pay

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Willingness to Pay for Cancer Prevention

By Hunt Timothy L.  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 299-312

Adis International

Access to resources Recommend Favorite

Plasma Adiponectin Levels in Post-menopausal Women Receiving Hormone Replacement Therapy

By Sumino H   Takahashi T   Itoh T   Kusaka K   Yamakawa J   Ichikawa S   Kurabayashi M   Kanda T  

The Journal of International Medical Research, Vol. 32, Iss. 6, 2004-11 ,pp. : 639-645

Field House Publishing

Access to resources Recommend Favorite